An open-label study to evaluate contraceptive efficacy and safety of the transdermal contraceptive system of 17d norgestimate and ethinyl estradiol [ethinylestradiol/norelgestromin] with the oral contraceptive Mercilon [ethinylestradiol/desogestrel]

Trial Profile

An open-label study to evaluate contraceptive efficacy and safety of the transdermal contraceptive system of 17d norgestimate and ethinyl estradiol [ethinylestradiol/norelgestromin] with the oral contraceptive Mercilon [ethinylestradiol/desogestrel]

Completed
Phase of Trial: Phase III

Latest Information Update: 14 May 2007

At a glance

  • Drugs Ethinylestradiol/desogestrel; Ethinylestradiol/norelgestromin
  • Indications Pregnancy
  • Focus Registrational; Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 27 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top